La Cité has been collaborating since 2011 with this Ottawa company to develop a system of lipid gas microbubble production designed to deliver medication. This biopharmaceutical research project involves researchers from the National Research Council of Canada (NRC) and from Toronto’s Sunnybrook Hospital. The microbubbles are first prepared by La Cité’s team, to the client’s specifications, before being sent to the NRC for preclinical cancer and Parkinson’s disease treatment trials. For cancer treatments, this approach helps to better target chemotherapy directly to the tumour where, with ultrasound, it is delivered locally, lessening the destruction of healthy cells. As well, new formulations developed over the course of the project avec been discovered to be able to pass through the blood brain barrier, which could have a significant impact on the treatment of neurodegenerative diseases. In this regard, Artenga received a grant from the Michael J. Fox Foundation in the summer of 2015 in support of its research efforts. The research aims to support the company in the development of technology that could revolutionize certain therapeutic approaches.